Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7347 | 1378 | 44.9 | 92% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
180 | 3 | DUCHENNE MUSCULAR DYSTROPHY//DYSTROPHIN//MUSCULAR DYSTROPHY | 56784 |
420 | 2 | JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY//RHO KINASE//MYOSIN | 16501 |
7347 | 1 | FASUDIL//RHO KINASE//Y 27632 | 1378 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FASUDIL | authKW | 2836035 | 14% | 67% | 192 |
2 | RHO KINASE | authKW | 2394202 | 25% | 31% | 349 |
3 | Y 27632 | authKW | 625231 | 6% | 33% | 85 |
4 | RHO KINASE INHIBITOR | authKW | 609488 | 4% | 51% | 54 |
5 | RHO ASSOCIATED KINASE | authKW | 369872 | 3% | 35% | 48 |
6 | ROCK2 | authKW | 356611 | 2% | 62% | 26 |
7 | HYDROXYFASUDIL | authKW | 256130 | 1% | 68% | 17 |
8 | ROCK | authKW | 253227 | 7% | 12% | 99 |
9 | ROCK INHIBITOR | authKW | 158242 | 1% | 36% | 20 |
10 | FASUDIL HYDROCHLORIDE | authKW | 155089 | 1% | 50% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Peripheral Vascular Diseases | 2189 | 12% | 0% | 169 |
2 | Cell Biology | 1270 | 17% | 0% | 235 |
3 | Cardiac & Cardiovascular System | 1209 | 13% | 0% | 175 |
4 | Pharmacology & Pharmacy | 841 | 17% | 0% | 228 |
5 | Biochemistry & Molecular Biology | 403 | 18% | 0% | 251 |
6 | Physiology | 372 | 7% | 0% | 91 |
7 | Chemistry, Medicinal | 257 | 5% | 0% | 66 |
8 | Neurosciences | 215 | 10% | 0% | 135 |
9 | Medicine, Research & Experimental | 207 | 6% | 0% | 79 |
10 | Hematology | 179 | 4% | 0% | 59 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELL PHARMACOL | 99717 | 3% | 12% | 37 |
2 | VASC MED UNIT | 82673 | 2% | 13% | 28 |
3 | GHOSH SCI TECHNOL | 69239 | 0% | 63% | 5 |
4 | ABORAT INNOVAT 2011 | 63858 | 1% | 41% | 7 |
5 | TECHNOL AGCY | 56970 | 0% | 43% | 6 |
6 | DRUG DISCOVERY S OSAKA | 44315 | 0% | 100% | 2 |
7 | INITIAT TEAM MICROENVIRONM | 44315 | 0% | 100% | 2 |
8 | COE PROGRAM LIFESTYLE RELATED DIS | 41748 | 1% | 27% | 7 |
9 | MAJOR CLIN | 39881 | 0% | 60% | 3 |
10 | SCI AFFAIRS SALES PROMOT | 33233 | 0% | 50% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 1218 | 2% | 0% | 25 |
2 | CIRCULATION RESEARCH | 1124 | 2% | 0% | 23 |
3 | HYPERTENSION | 1072 | 2% | 0% | 24 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 1039 | 1% | 0% | 19 |
5 | AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 752 | 2% | 0% | 21 |
6 | AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY | 736 | 1% | 0% | 14 |
7 | EUROPEAN JOURNAL OF PHARMACOLOGY | 661 | 2% | 0% | 30 |
8 | CARDIOVASCULAR DIABETOLOGY | 634 | 0% | 0% | 6 |
9 | DRUG NEWS & PERSPECTIVES | 517 | 0% | 1% | 4 |
10 | JOURNAL OF HYPERTENSION | 490 | 1% | 0% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FASUDIL | 2836035 | 14% | 67% | 192 | Search FASUDIL | Search FASUDIL |
2 | RHO KINASE | 2394202 | 25% | 31% | 349 | Search RHO+KINASE | Search RHO+KINASE |
3 | Y 27632 | 625231 | 6% | 33% | 85 | Search Y+27632 | Search Y+27632 |
4 | RHO KINASE INHIBITOR | 609488 | 4% | 51% | 54 | Search RHO+KINASE+INHIBITOR | Search RHO+KINASE+INHIBITOR |
5 | RHO ASSOCIATED KINASE | 369872 | 3% | 35% | 48 | Search RHO+ASSOCIATED+KINASE | Search RHO+ASSOCIATED+KINASE |
6 | ROCK2 | 356611 | 2% | 62% | 26 | Search ROCK2 | Search ROCK2 |
7 | HYDROXYFASUDIL | 256130 | 1% | 68% | 17 | Search HYDROXYFASUDIL | Search HYDROXYFASUDIL |
8 | ROCK | 253227 | 7% | 12% | 99 | Search ROCK | Search ROCK |
9 | ROCK INHIBITOR | 158242 | 1% | 36% | 20 | Search ROCK+INHIBITOR | Search ROCK+INHIBITOR |
10 | FASUDIL HYDROCHLORIDE | 155089 | 1% | 50% | 14 | Search FASUDIL+HYDROCHLORIDE | Search FASUDIL+HYDROCHLORIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHI, JJ , WEI, L , (2013) RHO KINASES IN CARDIOVASCULAR PHYSIOLOGY AND PATHOPHYSIOLOGY: THE EFFECT OF FASUDIL.JOURNAL OF CARDIOVASCULAR PHARMACOLOGY. VOL. 62. ISSUE 4. P. 341-354 | 185 | 68% | 40 |
2 | LOIRAND, G , (2015) RHO KINASES IN HEALTH AND DISEASE: FROM BASIC SCIENCE TO TRANSLATIONAL RESEARCH.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 4. P. 1074 -1095 | 150 | 74% | 5 |
3 | FENG, YB , LOGRASSO, PV , DEFERT, O , LI, RS , (2016) RHO KINASE (ROCK) INHIBITORS AND THEIR THERAPEUTIC POTENTIAL.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 59. ISSUE 6. P. 2269 -2300 | 108 | 57% | 7 |
4 | WEI, L , SURMA, M , SHI, S , LAMBERT-CHEATHAM, N , SHI, JJ , (2016) NOVEL INSIGHTS INTO THE ROLES OF RHO KINASE IN CANCER.ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS. VOL. 64. ISSUE 4. P. 259 -278 | 123 | 51% | 2 |
5 | DONG, M , YAN, BP , LIAO, JK , LAM, YY , YIP, GWK , YU, CM , (2010) RHO-KINASE INHIBITION: A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF CARDIOVASCULAR DISEASES.DRUG DISCOVERY TODAY. VOL. 15. ISSUE 15-16. P. 622-629 | 79 | 71% | 59 |
6 | GUAN, RG , XU, XY , CHEN, MH , HU, HY , GE, H , WEN, SJ , ZHOU, SY , PI, RB , (2013) ADVANCES IN THE STUDIES OF ROLES OF RHO/RHO-KINASE IN DISEASES AND THE DEVELOPMENT OF ITS INHIBITORS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 70. ISSUE . P. 613-622 | 58 | 87% | 26 |
7 | ZHOU, H , LI, YJ , (2012) RHO KINASE INHIBITORS: POTENTIAL TREATMENTS FOR DIABETES AND DIABETIC COMPLICATIONS.CURRENT PHARMACEUTICAL DESIGN. VOL. 18. ISSUE 20. P. 2964-2973 | 87 | 64% | 10 |
8 | HARTMANN, S , RIDLEY, AJ , LUTZ, S , (2015) THE FUNCTION OF RHO-ASSOCIATED KINASES ROCK1 AND ROCK2 IN THE PATHOGENESIS OF CARDIOVASCULAR DISEASE.FRONTIERS IN PHARMACOLOGY. VOL. 6. ISSUE . P. - | 86 | 53% | 9 |
9 | SHIMIZU, T , LIAO, JK , (2016) RHO KINASES AND CARDIAC REMODELING.CIRCULATION JOURNAL. VOL. 80. ISSUE 7. P. 1491 -1498 | 61 | 73% | 2 |
10 | SHIN, HK , SALOMONE, S , AYATA, C , (2008) TARGETING CEREBROVASCULAR RHO-KINASE IN STROKE.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 12. ISSUE 12. P. 1547-1564 | 106 | 56% | 14 |
Classes with closest relation at Level 1 |